This inventor holds 3 USPTO granted patents. Top assignees: Biostratum, Inc., Other. Active years: 1997-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2005
Title: The Innovations of Pekka Kallunki
Introduction
Pekka Kallunki is a notable inventor based in La Jolla, CA (US). He has made significant contributions to the field of diagnostics and therapeutics, particularly through his work with laminin chains. With a total of 3 patents to his name, Kallunki's inventions have the potential to impact medical practices significantly.
Latest Patents
Kallunki's latest patents focus on the diagnostic and therapeutic uses of laminin chains. One of his inventions, titled "Laminin chains: diagnostic uses," provides methods for the identification, diagnosis, monitoring, and treatment of invasive cells using the laminin 5 gamma-2 chain protein or nucleic acid sequence, or antibodies thereto. Another patent, "Laminin chains: diagnostic and therapeutic use," similarly addresses the identification and treatment of invasive cells through the same innovative approaches.
Career Highlights
Throughout his career, Kallunki has worked with various companies, including Biostratum, Inc. His work has been instrumental in advancing the understanding of invasive cells and their treatment options. His innovative approaches have garnered attention in the scientific community.
Collaborations
Kallunki has collaborated with esteemed colleagues such as Karl Kristian Tryggvason and Charles Pyke. These collaborations have further enriched his research and contributed to the development of his patents.
Conclusion
Pekka Kallunki's contributions to the field of diagnostics and therapeutics through his patents on laminin chains highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new diagnostic and treatment methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile